¡GoConqr estrena diseño! Cuéntanos qué te parece.

Test

ON13 Colorectal cancer

Usuario eliminado 16 preguntas Actualizado el 9 oct 2019

Hacer el test

Este test tiene tipos de pregunta que se abren en el reproductor de siempre.

Preguntas del test (16)

  1. 1Choose the incorrect epidemiology statement about colorectal cancer.
    1. A3rd most common cancer in the world​
    2. BHighest rates in undeveloped/third world nations​
    3. C95% of colorectal cancers are adenocarcinomas​
    4. D91% and 88% 5 year survival rate for early stages of colon and rectal cancer, respectively​
    5. E70% 5 year survival rate after tumor spreads to adjacent lymph nodes
    6. F12% 5 year survival rate after metastasis​
  2. 2NZ stats:
    - Eight New Zealander’s diagnosed each day​
    - [blank_start]Three[blank_end] New Zealander’s die from bowel cancer each day​
    - [blank_start]2nd highest[blank_end] cause of cancer death in New Zealand​
    - One of the highest rates in the [blank_start]world[blank_end] ​
    - Rates for [blank_start]women[blank_end] are highest in world ​
    - Less frequent in [blank_start]Maori[blank_end] vs. non-Maori
    1. AThree
    2. B2nd highest
    3. Cworld
    4. Dwomen
    5. EMaori
  3. 3Risk factors for colorectal cancer:
    [blank_start]Male[blank_end] sex​
    Age​ (older)
    History of colorectal cancer, [blank_start]polyps, T2DM, IBD​[blank_end]
    Inherited factors (e.g. familial adenomatous polyposis, [blank_start]family history[blank_end])​
    Lifestyle factors​
    Diet ([blank_start]red[blank_end] meat, processed food, high fat, low fibre)​
    Physical [blank_start]inactivity[blank_end]​
    Long term [blank_start]smoking[blank_end]​
    Excessive [blank_start]alcohol[blank_end]​
    Obesity
    1. AMale
    2. Bpolyps, T2DM, IBD​
    3. Cfamily history
    4. Dred
    5. Einactivity
    6. Fsmoking
    7. Galcohol
  4. 4Protective Factors​:
    Some evidence [blank_start]NSAIDs / Aspirin[blank_end] use (13-28% RRR)​
    [blank_start]Postmenopausal[blank_end] hormone use (RRR 35%)​
    Healthy BMI, physical [blank_start]activity[blank_end], smoking [blank_start]cessation[blank_end]​
    Fibre, fruits, vegetables, reduced meat consumption​
    [blank_start]Calcium and vitamin D[blank_end] supplementation​
    1. ANSAIDs / Aspirin
    2. BPostmenopausal
    3. Cactivity
    4. Dcessation
    5. ECalcium and vitamin D
  5. 5Screening usually starts at age 50​. Decreases mortality through early detection​.
    Methods:​
    [blank_start]Colonoscopy[blank_end] (every 10 years post-50)​
    Flexible [blank_start]sigmoidoscopy[blank_end] (every 5 years)​
    CT scan (every 5 years)​
    Double contrast [blank_start]barium enema[blank_end] (every 5 years)​
    Fecal occult blood tests ([blank_start]annually[blank_end])​
    1. AColonoscopy
    2. Bsigmoidoscopy
    3. Cbarium enema
    4. Dannually
  6. 6Which of these is not a symptom of bowel cancer?
    1. ATenesmus​ (continual or recurrent inclination to evacuate the bowels)
    2. BAdvanced: unintentional weight loss, iron-deficiency anemia, weakness​
    3. CBloating​
    4. DRectal bleeding​
    5. EAbdominal pain​
    6. FChanges in bowel habits ​
    7. GMucositis
  7. 7Diagnosis:
    History and physical exam​
    Colonoscopy [blank_start]or[blank_end] sigmoidoscopy​
    [blank_start]Biopsy[blank_end] (to confirm presence of cancer)​
    [blank_start]CT[blank_end] scanning (search for metastases)​
    Baseline [blank_start]labs[blank_end] (CBC, platelet, liver panel, renal panel, CEA, iron studies)​
    Pathological staging after tumor resection ([blank_start]TNM[blank_end])​
    Gene mutation testing (?)​
    1. Aor
    2. BBiopsy
    3. CCT
    4. Dlabs
    5. ETNM
  8. 8Staging:
    Stage 1 - tumour size T1 (no deeper than [blank_start]submucosa[blank_end]) and T2 ([blank_start]not all the way through muscularis[blank_end])
    Stage 2 - T3 ([blank_start]through[blank_end] muscularis)
    Stage 3 - N1 ([blank_start]1-3[blank_end] lymph nodes involved), N2 ([blank_start]>4[blank_end] lymph nodes involved)
    Stage 4 - M - [blank_start]distant[blank_end] metastases.
    1. Asubmucosa
    2. Bnot all the way through muscularis
    3. Cthrough
    4. D1-3
    5. E>4
    6. Fdistant
  9. 9Clinical factors associated with poor prognosis:​
    Bowel [blank_start]obstruction or perforation​[blank_end]
    High preoperative [blank_start]CEA​[blank_end]
    Distant [blank_start]metastases[blank_end]​
    Location of tumor in [blank_start]rectal or rectosigmoid[blank_end] area​
    Molecular markers (KRAS mutations MSI, BRAF mutations)​
    1. Aobstruction or perforation​
    2. BCEA​ (carcinoembryonic antigen)
    3. Cmetastases
    4. Drectal or rectosigmoid
  10. 10Treatment:
    Need to consider stage, performance status, patient preferences, comorbidities, age. Curability depends on tumor stage​.
    General approach:​
    [blank_start]Surgical resection[blank_end] of primary tumor is 1st line therapy (Stage 1, 2, 3)​
    Removal of tumor plus [blank_start]5cm[blank_end] of tumor free bowel and regional [blank_start]lymph nodes[blank_end] for cure​
    Adjuvant [blank_start]chemotherapy and/or radiation[blank_end] can be given to eliminate residual micrometastases ​

    if it's metastases (Stage 4)​?
    Classified as resectable, potentially resectable, or unresectable​
    [blank_start]Systemic chemotherapy[blank_end] is mainstay, radiation may be used for palliative purposes​
    1. ASurgical resection
    2. B5cm
    3. Clymph nodes
    4. Dchemotherapy and/or radiation
    5. ESystemic chemotherapy

Información

Descripción
El usuario ha eliminado su información de asignaturas Test sobre ON13 Colorectal cancer, creado por Usuario eliminado el 09/10/2019.
Autor
Usuario eliminado
Idioma
English
Visitas
67
Historial
Creado el 9 oct 2019 · actualizado el 9 oct 2019

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?